Quick Takeaways
- Helen M. Thackray has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,829,885.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Helen M. Thackray
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Helen M. Thackray is at least $2,829,885 dollars as of 02 Apr 2025. Helen M. Thackray is the Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $2.83M.
- Signature
- /s/ Alane P. Barnes, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Helen M. Thackray and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BIOCRYST PHARMACEUTICALS INC ($2,829,885).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Helen M. Thackray
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Chief R&D Officer | $2,829,885 | 31 Mar 2025 | ||
| IMGN | ImmunoGen, Inc. | Director | $0 | 12 Feb 2024 |
Insider Transactions Reported by Helen M. Thackray:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.